Relay Therapeutics Inc
RLAY · NASDAQ
Relay Therapeutics, Inc. operates as a biotechnology company. The Company develops durgs for the treatment of cancer. Relay Therapeutics serves customers in the United States.
Market Data
Price
$10.69
+0.55 (+5.42%)
Market Cap$1.81B
P/E Ratio—
EPS$—
52W High$11.43
52W Low$1.78
Beta1.63
Data from Finnhub · Updated Mar 11, 2026